Avalon to Release First Quarter 2006 Financial Results on May 10, 2006
May 02 2006 - 1:35PM
PR Newswire (US)
GERMANTOWN, Md., May 2 /PRNewswire-FirstCall/ -- Avalon
Pharmaceuticals, Inc. (Nasdaq and ArcaEx(R): AVRX) today announced
that it is scheduled to release financial results for the first
quarter of 2006, on Wednesday, May 10, 2006 after the close of the
U.S. financial markets. The Company will host a conference call on
Thursday, May 11, 2006 at 8:00 a.m. Eastern Time to provide a
company update and discuss the financial results for the quarter.
Interested investors, analysts, members of the media and the
general public can listen to the call live over the Internet from
the investor section of the Company's website or by dialing the
numbers listed below. Conference Call Details:
------------------------ Dial-In: 866-713-8307 (U.S.) 617-597-5307
(International) Passcode: 67310263 Webcast: Please go to
http://www.avalonrx.com/, Investors, within 15 minutes prior to the
call and select the webcast link. The conference call replay will
be available through June 30, 2006 on Avalon's website
(http://www.avalonrx.com/). About Avalon Pharmaceuticals Avalon
Pharmaceuticals is a biopharmaceutical company focused on the
discovery and development of small molecule therapeutics. Avalon
seeks to discover and develop novel therapeutics through the use of
a comprehensive, innovative and proprietary suite of technologies
based upon large-scale gene expression analysis which it calls
AvalonRx(R). Avalon Pharmaceuticals was established in 1999 and is
headquartered in Germantown, Maryland. DATASOURCE: Avalon
Pharmaceuticals CONTACT: Gary Lessing, Executive Vice President and
CFO of Avalon Pharmaceuticals, Tel: +1-301-556-9900, or Fax:
+1-301-556-9910, or Email: Web site: http://www.avalonrx.com/
Copyright